tamibarotene has been researched along with scopolamine hydrobromide in 1 studies
| Studies (tamibarotene) | Trials (tamibarotene) | Recent Studies (post-2010) (tamibarotene) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 198 | 10 | 105 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | tamibarotene (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igarashi, M; Kagechika, H; Shudo, K; Tateda, C; Yamazaki, N | 1 |
1 other study(ies) available for tamibarotene and scopolamine hydrobromide
| Article | Year |
|---|---|
A synthetic retinoid Am80 (tamibarotene) rescues the memory deficit caused by scopolamine in a passive avoidance paradigm.
Topics: Animals; Antibodies, Monoclonal; Avoidance Learning; Benzazepines; Benzoates; Dose-Response Relationship, Drug; Male; Memory Disorders; Nootropic Agents; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Wistar; Retinoids; Scopolamine; Tetrahydronaphthalenes; Time Factors; Trimethylsilyl Compounds | 2004 |